As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.
So let's look at two noteworthy recent insider buys.
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.
So let's look at two noteworthy recent insider buys.
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.
So let's look at two noteworthy recent insider buys.
At Nuveen New York AMT-Free Municipal Income Fund, a filing with the SEC revealed that on Wednesday, Vice President Michael A.
Perry bought 8,568 shares of NRK, at a cost of $13.48 each, for a total investment of $115,473.
Nuveen New York AMT-Free Municipal Income Fund is trading up about 0.6% on the day Thursday.
And at Evofem Biosciences, there was insider buying on Tuesday, by Chief Executive Officer Saundra L.
Pelletier who purchased 45,249 shares at a cost of $2.28 each, for a trade totaling $103,168.
Evofem Biosciences is trading down about 2.2% on the day Thursday.
Pelletier was up about 19.7% on the buy at the high point of today's trading session, with EVFM trading as high as $2.73 in trading on Thursday.